These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 32424672)

  • 1. Outcome of stem cell transplantation for Waldenström's macroglobulinemia: analysis of the Japan Society for Hematopoietic Cell Transplantation (JSHCT) Lymphoma Working Group.
    Sakurai M; Mori T; Uchiyama H; Ago H; Iwato K; Eto T; Iwasaki H; Kawata T; Takamatsu H; Yamasaki S; Takanashi M; Ichinohe T; Atsuta Y; Suzuki R
    Ann Hematol; 2020 Jul; 99(7):1635-1642. PubMed ID: 32424672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autologous or allogeneic stem cell transplantation in patients with Waldenstrom's macroglobulinemia.
    Anagnostopoulos A; Hari PN; Pérez WS; Ballen K; Bashey A; Bredeson CN; Freytes CO; Gale RP; Gertz MA; Gibson J; Goldschmidt H; Lazarus HM; McCarthy PL; Reece DE; Vesole DH; Giralt SA
    Biol Blood Marrow Transplant; 2006 Aug; 12(8):845-54. PubMed ID: 16864055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allogeneic hematopoietic stem cell transplantation allows long-term complete remission and curability in high-risk Waldenström’s macroglobulinemia. Results of a retrospective analysis of the Société Française de Greffe de Moelle et de Thérapie Cellulaire.
    Garnier A; Robin M; Larosa F; Golmard JL; Le Gouill S; Coiteux V; Tabrizi R; Bulabois CE; Cacheux V; Kuentz M; Dreyfus B; Dreger P; Rio B; Moles-Moreau MP; Bilger K; Bay JO; Leblond V; Blaise D; Tournilhac O; Dhédin N
    Haematologica; 2010 Jun; 95(6):950-5. PubMed ID: 20081058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of Autologous and Allogeneic Hematopoietic Cell Transplantation in Waldenström Macroglobulinemia: A Systematic Review and Meta-analysis.
    Parrondo RD; Reljic T; Iqbal M; Ayala E; Tun HW; Kharfan-Dabaja MA; Kumar A; Murthy HS
    Clin Lymphoma Myeloma Leuk; 2020 Oct; 20(10):e694-e711. PubMed ID: 32616401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stem cell transplantation (SCT) for Waldenstrom's macroglobulinemia (WM).
    Anagnostopoulos A; Giralt S
    Bone Marrow Transplant; 2002 Jun; 29(12):943-7. PubMed ID: 12098060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allogeneic Transplantation for Relapsed Waldenström Macroglobulinemia and Lymphoplasmacytic Lymphoma.
    Cornell RF; Bachanova V; D'Souza A; Woo-Ahn K; Martens M; Huang J; Al-Homsi AS; Chhabra S; Copelan E; Diaz MA; Freytes CO; Gale RP; Ganguly S; Hamadani M; Hildebrandt G; Kamble RT; Kharfan-Dabaja M; Kindwall-Keller T; Lazarus HM; Marks DI; Nishihori T; Olsson RF; Saad A; Usmani S; Vesole DH; Yared J; Mark T; Nieto Y; Hari P
    Biol Blood Marrow Transplant; 2017 Jan; 23(1):60-66. PubMed ID: 27789362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence of graft-versus-Waldenstrom's macroglobulinaemia effect after allogeneic stem cell transplantation: a single centre experience.
    Stakiw J; Kim DH; Kuruvilla J; Gupta V; Messner H; Lipton JH
    Bone Marrow Transplant; 2007 Aug; 40(4):369-72. PubMed ID: 17589533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of stem cell transplantation in Waldenstrom's macroglobulinemia.
    Chakraborty R; Muchtar E; Gertz MA
    Best Pract Res Clin Haematol; 2016 Jun; 29(2):229-240. PubMed ID: 27825469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autologous stem cell transplantation as a care option in Waldenström's macroglobulinemia.
    Usmani S; Sexton R; Crowley J; Barlogie B
    Clin Lymphoma Myeloma Leuk; 2011 Feb; 11(1):139-42. PubMed ID: 21454216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autologous and allogeneic stem cell transplantation in Waldenstrom's macroglobulinemia: review of the literature and future directions.
    Anagnostopoulos A; Aleman A; Giralt S
    Semin Oncol; 2003 Apr; 30(2):286-90. PubMed ID: 12720154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-dose chemotherapy followed by stem cell transplantation in patients with resistant Waldenstrom's macroglobulinemia.
    Anagnostopoulos A; Dimopoulos MA; Aleman A; Weber D; Alexanian R; Champlin R; Giralt S
    Bone Marrow Transplant; 2001 May; 27(10):1027-9. PubMed ID: 11438816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment recommendations in Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia.
    Gertz MA; Anagnostopoulos A; Anderson K; Branagan AR; Coleman M; Frankel SR; Giralt S; Levine T; Munshi N; Pestronk A; Rajkumar V; Treon SP
    Semin Oncol; 2003 Apr; 30(2):121-6. PubMed ID: 12720120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allogeneic stem cell transplantation in patients with de novo diffuse large B-cell lymphoma who experienced relapse or progression after autologous stem cell transplantation: a Korea-Japan collaborative study.
    Kim JW; Kim SW; Tada K; Fukuda T; Lee JH; Lee JJ; Kwon JH; Bang SM; Kim I; Yoon SS; Lee JS; Park S
    Ann Hematol; 2014 Aug; 93(8):1345-51. PubMed ID: 24633661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-dose therapy and autologous stem-cell transplantation in Waldenstrom macroglobulinemia: the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation.
    Kyriakou C; Canals C; Sibon D; Cahn JY; Kazmi M; Arcese W; Kolbe K; Gorin NC; Thomson K; Milpied N; Niederwieser D; Indrák K; Corradini P; Sureda A; Schmitz N
    J Clin Oncol; 2010 May; 28(13):2227-32. PubMed ID: 20368570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Favorable outcomes from allogeneic and autologous stem cell transplantation for patients with transformed nonfollicular indolent lymphoma.
    Villa D; George A; Seymour JF; Toze CL; Crump M; Lee C; Buckstein R; Stewart DA; MacDonald D; Foley R; Xenocostas A; Sabloff M; Chua N; Couture F; Larouche JF; Cohen S; Savage KJ; Connors JM; Panzarella T; Carney DA; Dickinson M; Kuruvilla J
    Biol Blood Marrow Transplant; 2014 Nov; 20(11):1813-8. PubMed ID: 25042735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Post-relapse survival in Waldenstrom macroglobulinemia patients experiencing therapy failure following autologous transplantation.
    Ahmed S; Zhao Q; Hanel W; Qazilbash MH; Patel K; Narra R; Kansagra A; Iqbal M; Awan FT; Christian B; Jaglowski SM; Kharfan-Dabaja MA; Hamadani M; Epperla N
    Hematol Oncol; 2022 Feb; 40(1):48-56. PubMed ID: 34763367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allogeneic hematopoietic stem cell transplantation in patients with diffuse large B cell lymphoma relapsed after autologous stem cell transplantation: a GITMO study.
    Rigacci L; Puccini B; Dodero A; Iacopino P; Castagna L; Bramanti S; Ciceri F; Fanin R; Rambaldi A; Falda M; Milone G; Guidi S; Martelli MF; Mazza P; Oneto R; Bosi A;
    Ann Hematol; 2012 Jun; 91(6):931-9. PubMed ID: 22245922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allogeneic stem-cell transplantation in patients with Waldenström macroglobulinemia: report from the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation.
    Kyriakou C; Canals C; Cornelissen JJ; Socié G; Willemze R; Ifrah N; Greinix HT; Blaise D; Deconinck E; Ferrant A; Schattenberg A; Harousseau JL; Sureda A; Schmitz N
    J Clin Oncol; 2010 Nov; 28(33):4926-34. PubMed ID: 20956626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allogeneic and autologous stem-cell transplantation in advanced Ewing tumors. An update after long-term follow-up from two centers of the European Intergroup study EICESS. Stem-Cell Transplant Programs at Düsseldorf University Medical Center, Germany and St. Anna Kinderspital, Vienna, Austria.
    Burdach S; van Kaick B; Laws HJ; Ahrens S; Haase R; Körholz D; Pape H; Dunst J; Kahn T; Willers R; Engel B; Dirksen U; Kramm C; Nürnberger W; Heyll A; Ladenstein R; Gadner H; Jürgens H; Go el U
    Ann Oncol; 2000 Nov; 11(11):1451-62. PubMed ID: 11142486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myeloablative allogeneic hematopoietic stem cell transplantation in patients who experience relapse after autologous stem cell transplantation for lymphoma: a report of the International Bone Marrow Transplant Registry.
    Freytes CO; Loberiza FR; Rizzo JD; Bashey A; Bredeson CN; Cairo MS; Gale RP; Horowitz MM; Klumpp TR; Martino R; McCarthy PL; Molina A; Pavlovsky S; Pecora AL; Serna DS; Tsai T; Zhang MJ; Vose JM; Lazarus HM; van Besien K;
    Blood; 2004 Dec; 104(12):3797-803. PubMed ID: 15280203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.